/s/ Alfred Sandrock5/10/2013Alfred SandrockSignature Date
EX-10.1 2 biib-2013630xex101.htm EXHIBIT BIIB-2013.6.30-EX10.1
Exhibit 10.1
May 7, 2013
Alfred Sandrock
Dear Al:
In my letter to you dated April 16, 2013, I invited you to become a member of the G8, effective May 15, at which time you would become an Executive Officer of Biogen Idec.
Upon consideration I would like to change the effective date of your membership. Accordingly, I invite you to become a member of the G8, effective June 3, 2013, on which date you will become an Executive Officer of the Company and thereby subject to all disclosure requirements related to Executive Officer status.
To confirm your acknowledgement of this new effective date, please sign and return this letter and keep a copy for your records.
Sincerely,
/s/ George Scangos
Acknowledged and agreed:
/s/ Alfred Sandrock | 5/10/2013 |
Alfred Sandrock | Signature Date |
CC: K. DiPietro
D. Rhoades
April 16, 2013
Alfred Sandrock
Dear Al:
I am delighted that you have decided to remain with Biogen Idec, and am pleased to extend to you the promotion offer detailed on the attached term sheet. Your promotion will be effective on the first payroll date following your acceptance of this offer.
Upon your acceptance of this offer I would also like to invite you to become a member of the G8, effective May 15, at which time you will become an Executive Officer of the company. You will be subject to all disclosure requirements related to Executive Officer status.
Al, once again, we are all very excited by your decision, and look forward to a great future together.
To confirm your acceptance of this offer, please sign and return this letter and keep a copy for your records.
Sincerely,
/s/ George Scangos
George Scangos,
Chief Executive Officer
ACCEPTED:
/s/ Alfred Sandrock | 4/16/2013 |
Alfred Sandrock | Signature Date |
CC: K. DiPietro
D. Rhodes
Promotion & Retention Offer | ||||||||
Incumbent: | Sandrock, Al | |||||||
New Level | 23 | |||||||
New Bonus Target | 50% of salary | |||||||
New Position | Group SVP, CMO | |||||||
Reports to | D. Williams, EVP R&D | |||||||
Biogen Idec Annual Compensation | ||||||||
Current Compensation | New Compensation | % Difference (New vs. Current) | Comments | |||||
Salary | $525,000 | $550,000 | 5% | |||||
Target Bonus | ||||||||
($) | $210,000 | $500,000 | 138% | Min bonus guarantee each year | ||||
(%) | 40% | (guaranteed) | ||||||
Target Cash | $735,000 | $1,050,000 | 43% | |||||
LTI Grant Value | $776,250 | $1,500,000 | 93% | Annual LTI guarantee each year | ||||
(guaranteed) | ||||||||
Total Compensation | $1,511,250 | $2,550,000 | 69% | |||||
BIIB Summary of Retention Elements | ||||||||
Promotion to L23 | New title of Group SVP, CMO | |||||||
50% bonus target with $500k guaranteed annual bonus minimum starting with the 2013 performance year | ||||||||
Cash Retention Bonus | $250k with no payback clause to be paid as soon as administratively feasible upon acceptance | |||||||
Annual LTI* | $1.5m Guaranteed annual grant value, beginning with 2014 grant; Awards based on LTI plan design and | |||||||
vehicles in place at the time of grant | ||||||||
Special 1x LTI Grant* | $5m LTI grant value with 4 year graded vest starting 2016; To be granted at the same time as the 2014 LTI | |||||||
annual award; LTI grant value to be based on 50% MSUs and 50% RSUs | ||||||||
*Note: Guaranteed annual and special 1x LTI grants not subject to retirement provision in the 2008 Omnibus Plan | ||||||||